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Abstract Liver cancer is one of the most common cancers
worldwide with high morbidity and mortality. Its molecular
mechanism hasn’t been fully understood though many studies
have been conducted and thus further researches are still needed
to improve the prognosis of liver cancer. Firstly, differentially
expressed genes (DEGs) between six Mdr2-knockout (Mdr2-
KO) mutant mice samples (3-month-old and 12-month-old)
and six control mice samples were identified. Then, the enriched
GO terms and KEGG pathways of those DEGs were obtained
using the Database for Annotation, Visualization and Integrated
Discovery (DAVID, http://david.abcc.ncifcrf.gov/). Finally,
protein-protein interactions (PPI) network of those DEGs were
constructed using STRING database (http://www.string-db.org/)
and visualized by Cytoscape software, at the same time, genes
with high degree were selected out. Several novel biomarkers
that might play important roles in liver cancer were identified
through the analysis of gene microarray in GEO. Also, some
genes such as Tyrobp, Ctss and pathways such as Pathways in
cancer, ECM-receptor interaction that had been researched
previously were further confirmed in this study. Through the
bioinformatics analysis of the gene microarray in GEO, we
found some novel biomarkers of liver cancer and further
confirmed some known biomarkers.
Keywords Liver cancer . Bioinformatics . Biomarker .
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Introduction
Liver cancer is one of the most common malignancies. It has a
high morbidity and mortality, especially in sub-Saharan Africa
and eastern Asia. The incidence of liver cancer has doubled or
even more in the past 15 years [1]. However, the molecular
mechanism of liver cancer is still largely unknown. For above
reasons, an increasing number of researches on liver cancer
have been conducted in recent years. Different molecular mech-
anism and various biomarkers related to liver cancer have been
identified. Through qRT-PCR and Western blotting, JianXin
et al. [2] have inferred that GOLPH3, which has higher expres-
sion level in gene and protein level of liver cancer patients
compared with that of the normal population, is a new biomark-
er for liver cancer. Mah et al. [3] have found that the
inflammation-related pathway NFkB plays an important role
in liver cancer by analyzing the methylation profile of 59 liver
cancer patients. Despite a great number of previous researches,
molecular mechanism of liver cancer has not been fully
grasped. Hence, further researches of molecular level, such as
researches of gene or protein, are still needed to find out new
molecular mechanism or biomarkers in an effort to improve the
prognosis, diagnosis and treatment of liver cancer.
Mdr2-knockout (Mdr2-KO) mice lack the liver-specific P-
glycoprotein responsible for phosphatidylcholine transport
across the canalicular membrane, which may result in dys-
functional phospholipid secretion [4]. Signs of inflammation
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are accompanied by an increase in plasma transaminase levels
and followed by enhanced connective tissue storage and fibro-
sis progression. As a consequence of chronic inflammation
and progressing fibrosis, Mdr2-knockout mice may develop
liver cancer between the ages of 12 and 15 months [5].
With the rapid growth of microarry and its implication in
cancer research, a lot of genes that are related to cancers (includ-
ing liver cancer) have been verified. For example, Yang et al. [6]
have found that Gα12 is an important therapeutic target for liver
cancer through cDNA microarray analysis. Xu et al. [7] have
verified, through microarray and RT-PCR technology, the role
of CXCL5 in liver cancer migration and invasion.
In this research, by analyzing the gene expression microar-
ray of liver cancer in GEO database, we further confirmed the
molecular mechanism and some biomarkers of liver cancer that
had been investigated previously. Moreover, genes, which had
not been researched but also had a great importance to liver
cancer, were also included in this research. Also, most of the
enriched GO terms and KEGG pathways of those genes were
related to liver cancer, especially cell cycle, immune response,
inflammatory response, pathways in cancer, MAPK signaling
pathway, Cell adhesion molecules and etc. In conclusion, our
finding can improve our understanding of liver cancer and
provide potential therapeutic targets for further studies.
Materials and Methods
Gene Expression Microarray Data
In this study, the gene expression microarray data set
GSE4612 was downloaded from the Gene Expression Omni-
bus (GEO, http://www.ncbi.nlm.nih.gov/geo/). GSE4612 [8]
is a gene expression profile data including six Mdr2 knockout
(Mdr2-KO)mutant mice samples(3-month-old and 12-month-
old) and six control mice samples(3-month-old and 12-month-
old). The platform of this microarray data is GPL339
[MOE430A] Affymetrix Mouse Expression 430A Array.
Preprocessing of the Microarray Data
Unwanted noise of the rawmicroarray datawas filtered out in the
preprocessing stage. The normalization of raw data and back-
ground correction was conducted via affy[9] package in R.
Moreover, multiple probes that corresponded to one gene symbol
were summarized–taking the average expression values of those
probes as the expression value of this gene. There were a total of
22,690 probes in the microarray and 13,687 gene symbols that
had no duplicate before and after preprocessing.
Get the Differentially Expressed Genes
After the preprocessing, the critical step was to get the differ-
entially expressed genes (DEGs) between the case samples
and the control samples. The tool used in this study was the
limma [10] package in R. t-test was conducted on the gene
expression values between case samples and control samples
and the genes with P value<0.05 and |log2(fold change)|>1
were selected out. According to those criteria, in the first step,
the DEGs between the case samples and the control samples
were selected out from 3-month-old mice and 12-month-old
mice respectively, then the overlapped genes between those
two list DEGs were selected out. The heatmap of the overlap-
ped DEGs was obtained through gplots package in R to visu-
alize their expression value in different samples.
GO Enrichment and KEGG Pathway Analysis of the DEGs
After getting the DEGs, GO enrichment and KEGG pathway
analysis of the DEGs were conducted. Here, the tool used in
this study was DAVID (http://david.abcc.ncifcrf.gov/)
(Database for Annotation, Visualization and Integrated
Discovery). It could be used to do functional annotation for
a list of genes, gene functional classfication or gene ID
conversion. In this study, the module used in this study was
the functional annotation. First, we submitted the DEGs list
into the database and selected Mus musculus in species
Table 1 The top 10 enriched GO terms of DEGs, which were sorted by P value in ascending
Category GOID GO name P value Gene number
CC GO:0005578 proteinaceous extracellular matrix 2.74E-08 25
CC GO:0005576 extracellular region 5.41E-08 70
CC GO:0031012 extracellular matrix 5.82E-08 25
CC GO:0044421 extracellular region part 7.71E-08 42
BP GO:0006955 immune response 1.98E-05 26
BP GO:0006952 defense response 2.54E-05 25
BP GO:0007155 cell adhesion 5.24E-05 28
BP GO:0022610 biological adhesion 5.37E-05 28
MF GO:0004197 cysteine-type endopeptidase activity 2.65E-04 8
BP GO:0006954 inflammatory response 2.88E-04 15
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column. Finally, the GO terms and the KEGG pathways with
P value smaller than 0.05 and at least five genes were selected
out as the enriched function of DEGs.
Construct the PPI Network of DEGs
To further investigate the molecular mechanism of liver
cancer, PPI network of the DEGs was constructed through
STRING database (http://www.string-db.org/). STRING is a
database that infers the interaction between genes through
analyzing the genomic data that comes from different
sources, such as high-throughput experiments, co-
expression data and the previous data and etc. Also, it
has a unique scoring framework which assigns the interac-
tion an integrated score to represent its confidence through
combining the score of the different sources. Here, we se-
lected the gene-gene interactions, whose integrated scores
were bigger than 0.4 (the default threshold in the STRING
database), to construct the PPI network and Cytoscape [11]
was used for visualization.
Fig. 1 The heatmap of the DEGs. In the figure ‘control_3m_n (n=1, 2,
3)’ is the 3-month-old mice in control samples; ‘control_12m_n (n=1, 2,
3)’ is the 12-month-old mice in control samples; ‘case_3m_n (n=1,2,3)’
is the 3-month-old mice in case samples; ‘case_12m_n (n=1,2,3)’ is the
12-month-old mice in case samples
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Select the Core Gene in the Network
To select core genes (the genes that might be more
likely involved in liver cancer) from PPI network, we
analyzed the topological structure of the network and
obtained the degree (the number of genes that directly
interact with the gene) of each gene. Here, we selected
the genes whose degree is beyond 10 as the core genes
in the network.
Results
Differentially Expressed Genes (DEGs)
There were 1898 DEGs in the 3-month-old mice and 864
DEGs in the 12-month-old mice between the case samples
and control samples. A total of 380 overlapped DEGs between
those two DEG lists were identified. From the heatmap
(Fig. 1), we could get that the gene expression ofMdr2 knock-
out samples were distinguished from the control samples,
meanwhile, the gene expression of 3-month-old samples were
distinguished from the 12-month-old samples, indicating that
obvious differences existed in these groups.
Enriched GO Terms and KEGG Pathways of DEGs
In this study, a total of 128 enriched GO terms and 23 KEGG
pathways were obtained. The top 10 enriched GO terms of the
DEGs according to P value were shown (Table 1). Table 1
indicated that the main enriched GO terms was the biological
process of cell, such as cell adhesion, regulation of cell
growth, regulation of cell cycle. Besides the cell biological
process, there were also some enriched GO terms related to
immune response, inflammatory response and etc.
The enriched KEGG pathways of the DEGs were shown in
Table 2. A few enriched KEGG pathways were directly relat-
ed to cancer, such as Pathways in cancer, Small cell lung
cancer, Bladder cancer. What’s more, it was possible that
other pathways had an important influence on the progression
of cancer via some biological process, such as Toll-like recep-
tor signaling, EMC-receptor interaction, MAPK signaling
pathway and etc. The KEGG pathways and their correspond-
ing gene number were shown in Fig. 2.
PPI Network of the DEGs and Core Genes in the PPI Network
The PPI (Fig. 3) network contained 244 nodes and 1053 edges.
The nodes represented the DEGs and the edges represented the
Table 2 The KEGG pathways enriched in DEGs
Category Pathway name Gene number P value
KEGG_PATHWAY mmu04612:Antigen processing and presentation 10 3.22E-04
KEGG_PATHWAY mmu05416:Viral myocarditis 10 4.11E-04
KEGG_PATHWAY mmu05200:Pathways in cancer 18 0.001908471
KEGG_PATHWAY mmu04110:Cell cycle 10 0.003677215
KEGG_PATHWAY mmu04512:ECM-receptor interaction 8 0.003769465
KEGG_PATHWAY mmu00590:Arachidonic acid metabolism 8 0.003769465
KEGG_PATHWAY mmu04514:Cell adhesion molecules (CAMs) 11 0.003969349
KEGG_PATHWAY mmu05320:Autoimmune thyroid disease 7 0.007639543
KEGG_PATHWAY mmu05310:Asthma 5 0.007822698
KEGG_PATHWAY mmu04672:Intestinal immune network for IgA production 6 0.00947486
KEGG_PATHWAY mmu04620:Toll-like receptor signaling pathway 8 0.009821668
KEGG_PATHWAY mmu04010:MAPK signaling pathway 14 0.011527368
KEGG_PATHWAY mmu05332:Graft-versus-host disease 6 0.012714159
KEGG_PATHWAY mmu05330:Allograft rejection 6 0.012714159
KEGG_PATHWAY mmu05222:Small cell lung cancer 7 0.016578151
KEGG_PATHWAY mmu04940:Type I diabetes mellitus 6 0.017724229
KEGG_PATHWAY mmu05219:Bladder cancer 5 0.018106115
KEGG_PATHWAY mmu04510:Focal adhesion 11 0.021349818
KEGG_PATHWAY mmu04670:Leukocyte transendothelial migration 8 0.024856275
KEGG_PATHWAY mmu04912:GnRH signaling pathway 7 0.029651851
KEGG_PATHWAY mmu00480:Glutathione metabolism 5 0.036428615
KEGG_PATHWAY mmu04710:Circadian rhythm 3 0.038159626
KEGG_PATHWAY mmu05322:Systemic lupus erythematosus 7 0.038193344
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interactions between the DEGs. A great number of genes of
higher degree, which were the core genes in the PPI network,
might relate to liver cancer more closely. The core genes and
their corresponding degree were shown in Table 3. Among
those core genes, Ctss and Tyrobp had the highest degree and
there were 28 genes whose degree was beyond 20.
Discussion
Although researchers have made considerable efforts in dis-
closing the mechanisms of liver cancer,current understanding
of the genetic alterations associated with the progression of
liver cancer has not yet to be elucidated. In this study, we
conducted genome-wide gene expression analysis by a high
throughput method to identify the DEGs from liver cancer
compared with normal liver tissues. Here, a total number of
380 overlapped DEGs from original dataset of two groups (3-
month-old group and 12-month-old group) were identified,
including 289 overexpressed genes, 66 down-regulated genes
and 25 genes that had contradictory expression trend.
GO analyses revealed that the significant ontology catego-
ries included immune response, cell adhesion, inflammatory
response and so on. Immune effector process, nuclear divi-
sion, cell division, mitotic cell cycle and positive regulation
of cellular component organization were obviously overrepre-
sented in the up-regulated genes according to the functional
enrichment analysis. In the immune response, for example,
TLR2 could enhance ovarian cancer stem cell self-renewal
and eventually promote tumor repair and recurrence [12].
ICAM-1 is a transmembrane glycoprotein in the immunoglob-
ulin superfamily, which participates in oral cancer progression
and induces macrophage/SCC-cell adhesion [13]. Ciftci et al.
[14] indicated that serum TGFB1 level might be elevated in
breast cancer patients and had a favorable prognostic value.
CDH1, involved in cell adhesion, can code the adhesion pro-
tein E-cadherin that plays a central part in the process of epi-
thelial morphogenesis [15]. CCL5 belongs to the CC-
chemokine family and plays a pivotal role in the invasion
and metastasis of human cancer cells. Huang et al. reported
that CCL5 stimulation could increase lung cancer migration
Fig. 2 The PPI network of the DEGs. The network contains 244 nodes
and 1053 edges. The 198 crimson nodes are the genes that have higher
expression values in the case samples compared with the control samples
in both 3-month-old mice and 12-month-old mice; the 34 bright green
nodes are the genes that have lower expression values in the case samples
compared with the control samples in both 3-month-old mice and 12-
month-old mice; the 12 blue nodes represent the genes that have
contradictory expression trend between case samples and control
samples in 3-month-old mice and 12-month-old mice
Fig. 3 The KEGG pathway and
their corresponding gene number
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via induced phosphorylation of the p85α subunit of PI3K and
serine 473 of Akt [16].
DEGs were then used in KEGG pathway analyses and 23
pathways were screened out, such as Cell adhesion molecules,
Toll-like receptor signaling, EMC-receptor interaction,
MAPK signaling pathway and etc. Previous researches report-
ed that most of these pathways were involved in cancer pro-
gression. The immune system played a critical role in body
defense system, and the dysfunction of immune system might
result in cancer. Stimulation of various Toll-like receptors in-
duced specific patterns of gene expression, which resulted in
the activation of innate immunity and the development of
antigen-specific acquired immunity [17]. Moreover, MAPK
signal molecules participated in the amplification and speci-
ficity of the transmitted signals that finally activated a number
of regulatory molecules in the cytoplasm and the nucleus to
initiate cellular processes such as proliferation, differentiation,
and development [18].
Furthermore, the topological structure analysis of PPI
network suggested that Ctss, Tyrobp, Vim, Cdk1 were
the top 4 core genes, which might be potential thera-
peutic targets for future research. Cathepsin S (Ctss), a
key enzyme in major histocompatibility complex class II
(MHC-II) mediating antigen presentation, might be in-
volved in malignant progression of lung cancer [19].
CD47 positive liver cancer cells preferentially secreted
cathepsin S (CTSS), which regulated liver tumor-
initiating cells through the CTSS/protease-activated re-
ceptor 2 (PAR2) loop [20]. Shabo indicated that Tyrobp
(DAP12) in breast cancer was associated with an ad-
vanced tumor grade and higher rates of skeletal and
liver metastases [21, 22]. Costa reported that Vim could
associate with GDF15 and TMEFF2 to predict bladder
cancer [23].
Overall, with a microarray data set from the GEO da-
tabase, a range of DEGs were obtained in liver cancer and
normal tissues. These genes might be functionally relevant
to pathogenesis of liver cancer. Functional analysis re-
vealed mitotic cell cycle, proteinaceous extracellular matrix
and MAPK signaling pathway participated in biological
processes as the significant items for liver cancer. These
results could provide a valuable data base for further in-
vestigation of liver cancer research. Of course, further ex-
periments are still needed to further confirm the potential
function of these genes.
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Table 3 The core genes and their
corresponding degree
a The number of genes that
directly interact with the genes in
the PPI network
Gene Degreea Gene Degree Gene Degree Gene Degree
Lum 10 Fbn1 15 Mcm5 19 Cdh1 24
Tpm4 10 Itga6 15 Cdca5 19 Ccnd1 25
Lyz1 10 Lgals1 15 Tlr2 20 Jun 25
Gbp2 10 S100a6 15 Serpinh1 20 Fos 25
Max 11 Fermt3 16 Lyz2 20 Cd86 25
Gm3776 11 P2ry6 16 Cd53 20 Rmcs2 25
Col4a2 11 Ccnf 17 Clec4n 20 Birc5 25
Ctgf 12 Chtf18 17 H2-Aa 20 Ccnb2 25
Arhgdib 12 C1qa 17 Prim1 20 Ccl5 26
Cd14 12 Anln 17 Mcm6 20 Ly86 26
H2-L 12 Col5a2 17 Rrm2 20 Icam1 27
Cd74 12 Cybb 17 Kif20a 20 Mki67 27
F2r 12 Col3a1 18 Slc15a3 21 Aurka 27
Efemp2 13 Dcn 18 Clec7a 22 Itgb2 27
Cyba 13 C1qc 18 Plk1 22 Mmp2 28
Rock2 13 Myc 18 Chek1 22 Cdk1 30
Ccl9 13 Psmb8 18 Cd52 22 Vim 31
Topbp1 14 Fstl1 19 Bgn 23 Tyrobp 37
Col4a1 14 Ccl6 19 Aif1 24 Ctss 37
Nis1 14 Rrm1 19 Mpeg1 24
Cenpq 15 Top2a 19 Tgfb1 24
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